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Objectives. The purpose of this study was to evaluate the efficacy 
and safety of radiofrequency catheter ablation of common atrial 
flutter and to determine the optimal target sites in a large series 
of patients. 
Background. Recent studies report the efficacy of radio- 
frequency current application in the low right atrial region to 
interrupt and prevent recurrences of common atrial flutter. 
However, larger groups of patients are required to confirm the 
efficacy of this technique and to specify the target sites. 
Methods. Two different approaches were used to target the 
ablation site in 80 consecutive patients. In the first 50 patients, 
target sites were localized using both anatomic landmarks and 
electrophysiologic variables. Three anatomic landmarks were 
used: area 1 = between the tricuspid valve and inferior vena cava 
orifice; area 2 = between the tricuspid valve and coronary sinus 
ostium; area 3 = between the inferior vena cava and coronary 
sinus. The electrophysiologic criterion was to ablate when there 
was a stable atrial electrogram during the plateau phase. In the 
next 30 patients we assessed the effect of application of radio- 
frequency energy in a single line in area 1, 2 or 3 in groups of 10 
patients. 
Results. Overall atrial flutter was interrupted and rendered 
noninducible after a single session in 72 patients (90%) and could 
not be interrupted in 8 (10%). The mean (-+SD) number of 
radiofrequency applications was 12 + 8. After a mean (-+SD) 
follow-up of 20 -+ 8 months, recurrences occurred in 14 patients 
(17%). The location of the final successful site in the first group of 
50 patients was in area 1 in 39%, area 2 in 36% and area 3 in 25%. 
In the next 30 patients, when lines of radiofrequency lesions were 
placed at several sites, they produced success rates of 70%, 40% 
and 10% at areas 1, 2 and 3, respectively. 
Conclusions. Radiofrequency catheter ablation of atrial flutter 
can be performed with a high success rate and is safe. The highest 
success rate is achieved with radiofrequency energy applied in the 
isthmus between the inferior vena cava orifice and tricuspid valve. 
(J Am Coil Cardiol 1995;25:1365-72) 
Common atrial flutter, sometimes referred to as type I, is a 
supraventricular t chycardia that is frequently disabling and 
drug resistant. It is defined as an atrial tachycardia with a 
constant rate, polarity and configuration on electrograms and a 
"sawtooth" pattern consisting of inverted P waves in the 
inferior leads. The P waves are biphasic in leads 1 and V~, and 
upright in V I. In this report the designation flutter refers to 
common flutter unless otherwise specified. Its mechanism is a 
macro reentrant circuit involving the right atrium (1,2). The 
exact location of the reentrant circuit is uncertain but appears 
to involve the isthmus between the inferior vena cava and the 
tricuspid valve, the isthmus between the (septal) tricuspid valve 
and the coronary sinus ostium and the isthmus between the 
coronary sinus ostium and the inferior vena cava orifice (3-7). 
Three recent reports (8-10) have described the effects of 
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radiofrequency ablation in atrial flutter using either anatomic 
or electrophysiologic targets. In the present study, we report 
our experience in 80 patients who underwent catheter ablation 
for treatment of atrial flutter. Two different approaches were 
used sequentially to target he ablation site. The first used a 
combined anatomic and electrophysiologic approach; the sec- 
ond used only anatomic guidelines. 
Methods  
Study patients. Eighty consecutive patients referred to a 
single institution between April 1991 and March 1994 for 
treatment of symptomatic drug-resistant a rial flutter were 
studied (71 men, 9 women; mean [_+SD] age 59 _+ 12 years, 
range 20 to 80). Pertinent characteristics of the study group are 
summarized in Table 1. Of note is that 39% of the patients had 
structural heart disease. Flutter was paroxysmal in 29 patients 
(36%) and permanent in 51 (64%). Paro~smal episodes 
occurred at least once a week. At the time of evaluation, 13 
patients were in sinus rhythm. Two or more antiarrhythmic 
drugs were ineffective in preventing recurrences of the atrial 
flutter in 67 patients. Eight patients also had previously 
documented atypical atrial flutter in addition to the common 
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Table 1. Clinical Characteristics of 80 Study Patients 
Age (yr) 59 - 12 
Gender (M/F) 71/9 
Types of heart disease 
None 49 
Hypertensive heart disease 10 
Coronary artery disease 10 
Valvular heart disease 4 
Chronic obstructive lung disease 3 
Miscellaneous 4 
Arrhythmia feature 
Permanent AFL 51 
Paroxysmal AFL 29 
Paroxysmal AF 25 
Data presented are mean value _+ SD or number of patients. AF - atrial 
fibrillation; AFL - atrial flutter; F = female; M = male. 
form. Atypical or uncommon atrialflutter is defined as an atrial 
tachycardia with constant rate, polarity and configuration on 
electrograms but without he "sawtooth" pattern. The P waves 
are usually positive in the inferior limb leads of the surface 
electrocardiogram (ECG). Twenty-five patients (31%) had 
previously documented episodes of paroxysmal atrial fibrilla- 
tion, and four of these patients had both atypical flutter and 
atrial fibrillation. 
Eleetrophysiologic study. Electrophysiologic studies were 
performed in each patient after informed oral consent had 
been obtained. Amiodarone was continued in 20 patients with 
frequent episodes or incessant supraventricular arrhythmias. 
Antiarrhythmic drugs were discontinued in the other patients 
at least 48 h before the study. Spontaneous persistent common 
atrial flutter was present in all but 13 patients at the time of 
electrophysiologic study. In these 13 patients atrial burst 
pacing was delivered to induce sustained atrial flutter. Atrial 
flutter was induced in eight patients, and atrial fibrillation in 
five. In the latter patients, infusion of amiodarone (150 mg 
intravenously over 5 min) or flecainide acetate (1 mg/kg body 
weight intravenously over 10 min), or both, was used to obtain 
sustained common atrial flutter. Two multielectrode catheters 
with 2- or 5-ram interelectrode spacing (Bard Electrophysiol- 
ogy) were introduced percutaneously through the right femoral 
and left subclavian veins to record His bundle and proximal 
coronary sinus activity during the procedure. A third catheter 
was introduced for mapping and ablation through the right 
femoral vein. This was a 7F steerable quadripolar catheter with 
a 4-mm tip electrode. Three ECG leads (usually II, III and 
aVF) and three intracardiac electrograms were recorded si- 
multaneously ata paper speed of 100 mm/s with a polygraph 
(mode VR 12, Electronics-for-Medicine). Amplification in the 
range of either 0.2 or 0.1 mV/cm was used to record bipolar 
intracardiac electrograms with filter settings of 30 to 500 Hz. 
Catheter endocardial mapping of the right atrium and coro- 
nary sinus during atrial flutter was performed only to demon- 
strate the counterclockwise atrial activation sequence (6,7). 
The three sites studied were the right atrial free wall, His 
bundle region and proximal coronary sinus. No specific elec- 
trophysiologic maneuvers were performed, such as attempting 
to demonstrate entrainment (11). Timing of the atrial electro- 
gram during atrial flutter was defined as the time from the 
onset of the earliest atrial spike (>0.1 mV) to the onset of the 
F wave on the surface ECG, defined as the negative deflection 
after the plateau. During some procedures, we infused pro- 
panolol (1 mg/kg intravenously) to increase atrioventricular 
(AV) block when high ventricular rates made interference 
from the QRS complex or T wave a problem. 
Target sites. Two different methods were used to localize 
the target sites. Method 1. In the first 50 patients we used a 
combined anatomic and electrophysiologic approach. We 
sought o determine whether there was a specific anatomic 
location or a specific electrogram at the site of atrial flutter 
interruption. Radiofrequency energy was applied to the three 
regions bounded by the tricuspid annulus, coronary sinus 
ostium and inferior vena cava orifice: area 1 = the region 
between the posterior tricuspid annulus and the orifice of the 
inferior vena cava; area 2 = the region between the septal 
tricuspid annulus and the coronary sinus ostium; area 3 = the 
region between the orifices of the inferior vena cava and the 
coronary sinus. In these areas the local electrograms occurred 
during the "plateau phase" preceding the F wave. Radio- 
frequency energy was delivered to one of these three areas 
where the most stable catheter position was first obtained. 
Therefore, the first application of radiofrequency energy dif- 
fered in site from one patient o another, but it was not given 
in random order or in a fixed sequence. We recorded the 
location where atrial flutter was terminated uring radiofre- 
quency delivery of energy as well as the timing of electrograms 
related to the onset of the F wave at the successful site. 
Analysis of these data indicated that all three areas were 
potential sites for atrial flutter interruption (see Results). 
Method Z For the next 30 patients, we assessed the effect of 
a single line of radiofrequency energy applied to each of the 
three areas. In Patients 51 to 60, radiofrequency energy was 
applied to area 1, starting at the tricuspid annulus and extend- 
ing to the orifice of the inferior vena cava; in Patients 61 to 70, 
radiofrequency energy was applied to area 2 by withdrawing 
the ablation catheter f om the tricuspid valve to the coronary 
sinus ostium, and in Patients 71 to 80, radiofrequency energy 
was applied to area 3. In both areas 1 and 2, the first ablation 
site showed a low AV ratio, and the subsequent sites gave a 
progressively increasing AV ratio. In the latter situation, the 
catheter was first positioned at the coronary sinus ostium and 
then progressively withdrawn toward the inferior vena cava 
orifice. When atrial flutter was not interrupted after radio- 
frequency energy was delivered to the area as described, other 
applications were delivered at the other two areas, depending 
on where the most stable catheter position was found. 
Ablation procedure. Care was taken to locate a stable 
catheter position. This was assessed by stable electrogram 
amplitudes rather than by degree of catheter excursion on 
fluoroscopy. Radiofrequency energy was delivered as a contin- 
uous unmodulated sine-wave output from a HAT 200 (Osypka 
GmbH) generator that delivers current at 500 kHz between the 
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distal electrode of the ablation catheter and a ll0-cm 2 cuta- 
neous patch electrode placed over the left scapula. A power 
setting of 12 to 30 W was used, depending on the tolerance to 
pain experienced by the patient. Actual delivered root-mean- 
squared current and voltage were continuously monitored 
during energy delivery. The surface ECG and the catheter 
position were monitored uring energy delivery. In the first 50 
patients, endocardial bipolar electrograms were not recorded 
at the time of ablation because of electrical interference during 
energy delivery. Radiofrequency energy was applied for 60 to 
90 s at each site except when there was an impedance increase 
or catheter displacement. The application was considered 
effective if the local electrogram amplitude had decreased 
significantly after ablation. If no change occurred, the applica- 
tion was repeated using a higher power. 
Immediately after successful interruption of atrial flutter 
and 10 to 20 rain later, induction of atrial flutter was attempted 
with rapid atrial burst pacing at decreasing cycle lengths (250 
to 150 ms). No isuprel infusion was used. When sustained atrial 
flutter was still inducible, the ablation procedure was contin- 
ued. When a sustained uncommon atrial flutter was induced, 
catheter endocardial mapping was performed to study the 
atrial activation sequence. If a reverse sequence of atrial flutter 
was confirmed, the ablation procedure was continued (10). If 
sustained atrial fibrillation was induced, the ablation session 
was stopped, and the patient was given intravenous amioda- 
rone (150 to 300 mg intravenously over 5 to 10 rain) until 
conversion to sinus rhythm. If atrial flutter could not be 
interrupted by radiofrequency energy after 4 h, and this 
occurred in eight patients (10%), the session was ended. Atrial 
flutter was then terminated by right atrial pacing, and the 
procedure was considered to be a failure. After the ablation 
procedure, subcutaneous low weight heparinate was given at 
2,500 U three times a day for 4 days. Twenty-four hour Holter 
monitoring was performed on the first and third days after 
ablation. Transthoracic echocardiograms were obtained be- 
tween the second and fourth days after the procedure. Patients 
were discharged on the fourth postprocedure day without any 
antiarrhythmic drug, except for six patients who had frequent 
episodes of atrial fibrillation before ablation. 
Patient follow-up. The mean follow-up period was 20 + 8 
months for the entire group. Information regarding clinical 
arrhythmia recurrence was obtained from the patient's physi- 
cian by telephone. In the unusual case in which the physician 
could not provide the needed information, the patient was 
contacted directly. Aspirin (250 rag/day) was prescribed for the 
first 3 months after ablation to reduce the risk of systemic 
emboli in the event of recurrence of atrial flutter or atrial 
fibrillation. Warfarin was prescribed for six patients who had 
frequent episodes of atrial fibrillation before ablation. 
Statistical analysis. Results are expressed as group mean 
value + SD. Quantitative variables were compared using a 
nonparametric test (Kruskall-Wallis test), and the exact Fisher 
test was used for qualitative variables. Statistical significance 
was selected at p < 0.05. Actuarial analysis was used to analyze 
the time to possible development of recurrence after successful 
ablation of atrial flutter. 
Resu l ts  
Ablation in the first 50 patients. Atrial flutter was inter- 
rupted and rendered noninducible after a single session in 43 
patients and could not be interrupted in 7. The number of 
radiofrequency applications in patients with noninducible 
atrial flutter was 16 + 9 (range 1 to 41) and 17 + 7 (range 5 to 
32) in those with inducible atrial flutter. Six of the 7 patients 
with atrial flutter that could not be interrupted were among the 
first 12 patients of this series. Mean duration of the radio- 
frequency energy application that preceded interruption of 
atrial flutter was 22 + 16 s (range 1 to 59). Prolongation 
(>20 ms) of the atrial flutter cycle length was observed in 13 
patients (30%) before interruption. In three patients radiofre- 
quency application induced local atrial premature beats that 
terminated the atrial flutter, but the arrhythmia was again 
inducible by programmed atrial stimulation and required 
further energy delivery for permanent interruption. 
In two patients atrial flutter was interrupted and rendered 
noninducible after a single application of radiofrequency en- 
ergy. Their successful sites were located in areas 2 and 3 and 
showed a pattern of double spikes in one patient and a single 
spike in the other during tachycardia. No recurrence occurred 
in these two patients after 18 and 20 months of follow-up, 
respectively. 
The radiologic location of the final successful ablation site 
was estimated to be in area 1 in 39% of patients, in area 2 in 
36% and in area 3 in 25% (Fig. 1). Atrial electrogram patterns 
at the site of interruption ofatrial flutter showed a single spike 
in 46% of patients with activation times occurring - 86 +_ 23 ms 
(range -20 to -130 ms) before inverted P wave onset. In 28% 
of patients, double spikes were observed, with the first occur- 
ring -70 _+ 25 ms (range -100 to -30 ms) before F wave 
onset. In 26% of patients, multiple or fragmented lectrograms 
(width 80 _+ 12 ms) were observed, with the first electrogram 
occurring -51 _+ 21 ms (range -100 to -35 ms) before F wave 
onset. The timing of the electrograms relative to F wave onset 
is illustrated in Figure 2. The atrial electrogram patterns at the 
site of common atrial flutter interruption relative to the 
location of the final successful ablation site are summarized in
Table 2. The atrial and ventricular electrogram amplitudes 
were 0.77 + 0.53 mV (range 0.1 to 2 mV) and 0.2 _+ 0.37 (range 
0.0! to 1.2 mV), respectively, with an AV ratio of 7.8 + 7.8 
(range 0.3 to 24). The AV ratio at successful sites in area 1 was 
6.7 z 9.5 (range 20 to 0.17), in area 2, 7 _+ 5.7 (range 10 to 
0.10) and in area 3, 10.6 _+ 6.5 (range 20 to 0.8). 
In sinus rhythm, atrial electrogram patterns at the final 
successful ablation site showed double spikes in 27 patients 
(63%), fragmented activity in 7 (14%) and single potential in 9 
(23%). Atrial and ventricular electrogram amplitudes were 
0.44 _+ 0.48 mV (range 0.03 to 2 mV) and 0.12 + 0.27 mV 
(range 0.01 to 0.75 mV), respectively, with an AV ratio of 
5.5 _+ 6 (range 0.13 to 25). 
1368 FISCHER ET AL. JACC Vol. 25, No. 6 
RADIOFREQUENCY ABLATION OF ATRIAL FLU'FFER May 1995:1365-72 
"! 
k ,, 
7 
- 245 
15 
2 
| r 
-130 -110 -90  -70 -50 -30 o (MSEC 
Figure 2. Timing of the atrial electrogram at the final successful site 
relative to the onset of the F wave in the first group of 50 patients; 
245 ms represents he mean atrial flutter cycle length in these patients. 
Numbers above bars are the number of patients. 
Figure 1. Right anterior oblique 30 ° (left) and left anterior oblique 60 ° 
(right) views at the "final" successful ablation site in several represen- 
tative patients. Radiographic position of the ablation catheter (arrow- 
head) is shown relative to the multipolar catheter in the corona~ sinus 
(CS) and the quadripolar His bundle catheter (H). The final successful 
ablation site is located in the myocardial isthmus between the inferior 
vena cava orifice and tricuspid valve (area 1) in the first patient (top), 
the tricuspid valve and coronary sinus ostium (area 2) in the second 
patient (middle) and the coronary, sinus and inferior vena cava orifice 
(area 3) in the third patient (bottom). 
Lines of radiofrequency lesions at various sites. When 
radiofrequency lesions were applied at area 1, 2 or 3 in the last 
30 patients, atrial flutter was interrupted in 7, 4 and 1 patient, 
respectively. Mean number of radiofrequency applications was 
7 _+ 8 (range 2 to 21), 8 _+ 6.5 (range 2 to 19) and 9 ± 8 (range 
3 to 35), respectively. In 18 patients the first targeted area was 
unsuccessful, but atrial flutter was successfully interrupted at 
subsequent sites in 17 patients (Table 3). Electrophysiologic 
and demographic haracteristics of these 30 patients are 
summarized in Table 4. 
Additional observations. In six patients, application of 
radioffequency energy just above the coronary sinus ostium 
produced a dramatic and permanent decrease in the ventricu- 
lar rate from a 2:1 response to a 4:1 or 5:1 response without any 
modification of the atrial flutter cycle length. In all these 
patients the PR interval was unchanged after resumption of 
sinus rhythm. In three patients the maximal AH interval 
observed uring decremental pacing was <180 ms, suggesting 
the presence of a fast AV node pathway only. 
Complications. Complications consisting of groin hema- 
toma occurred in six patients (7.5%). Thrombi or pericardial 
effusion were not detected by routine echocardiography after 
the procedure. Twenty-four hour Holter monitoring detected 
recurrence of the atrial flutter in three patients. 
Follow-up. All patients were follow-up for a mean of 20 + 
8 months (range 8 to 45). In the subgroup of patients with 
recurrence of atrial flutter, the follow-up period was 19 2 9 
months. Fifty-four patients (68%) were free of symptoms and 
have had no recurrence of atrial flutter. Four patients (5%) 
had episodes of atrial fibrillation not previously documented. 
Fourteen patients (17%) had recurrences of atrial flutter 
(occurring 11 + 12 weeks after the first ablation session). 
According to actuarial analysis (Fig. 3), the probability of 
successful atrial flutter ablation was 84% at 40 weeks. Ten of 
these 14 patients underwent a second or third (two patients) 
session without further recurrence. In the 10 patients who 
underwent further sessions for atrial flutter recurrence, the 
atrial flutter was interrupted in the same final successful site in 
3 patients. In each of these three patients, identical previous 
atrial electrogram patterns (and timings) were recorded at the 
site of atrial flutter interruption. Atrial flutter interruption 
occurred after only one radiofrequency energy application in 
these three patients. In the seven other patients, final success- 
ful sites and atrial electrogram patterns (and timings) at the 
site of atrial flutter interruption were clearly distinct. Clinical 
and electrophysiologic variables for these 14 patients com- 
pared with those for 66 patients without recurrences are shown 
in Table 5. Number of applications of radiofrequency energy 
Table 2. Atrial Electrogram Patterns at Site of Common Atrial 
Flutter Interruption Relative to Location of Final Sucessful Ablation 
Site in First 50 Patients 
Pattern Area l Area 2 Area 3 
Single spike 72% 30% 17% 
Double spikes 5% 30% 50% 
Multiple or fragmented 23% 40% 33% 
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Table 3. Results of Lines of Radiofrequency Lesions at Various Sites 
Area 1 (n = 10 pts) Area 2 (n = 10 pts) Area 3 (n = 10 pts) 
Success Failure Success Failure Success Failure 
(7 pts) (3 pts) (4 pts) (6 pts) (1 pt) (9 pts) 
Area 2 Area 3 Area 2 
Success Failure Success Failure Success Failure 
(2 pts) (1 pt) (2 pts) (4 pts) (3 pts) (6 pts) 
Area 3 Area 1 Area 1 
Failure Success Success 
(1 pt) (4 pts) (6 pts) 
pt (pts) = patient (patients). 
was the only negative predictive variable of long-term out- 
come. We could not discern any positive predictive variable. 
Overall, 80% of the 80 patients are free of atrial flutter after 
one or multiple sessions, whereas 20% had episodes of atrial 
flutter or atrial fibrillation, or both (Table 6). 
Discuss ion  
Radiofrequency ablation of atrial flutter. Initially, catheter 
ablation of atrial flutter was performed by applying direct 
current energy to the low posteroseptal right atrium guided by 
double or fragmented atrial potentials during atrial flutter 
(12-14). Despite immediate good results, long-term follow-up 
has shown a high rate of recurrence (13). In our experience 
only 9 of 27 patients treated by direct current energy are free 
of flutter with a mean follow-up of 4 years (unpublished 
Table 4. Comparison fElectrophysiologic and Demographic 
Patient Characteristics of the Three Specific Flutter Ablation 
Procedures and All Study Patients 
Area 1 Area 2 Area 3 All 
Group Group Group Patients 
(n = 10) (n = 10) (n = 10) (n = 80) 
Gender (M/F) 9,,'1 10/0 9/1 71/9 
Age (yr) 56 _+ 10 65 _+ 6.5 58 _+ 7 59 _+ 12 
Cardiac disease 4 (40%) 3 (30%) 3 (30%) 31 (38.7%) 
Permanent AFL 6 (60%) 7 (70%) 7 (70%) 51 (63.7%) 
Paroxysmal AFL 4 (40%) 3 (30%) 3 (30%) 29 (36.2%) 
Atypical AFL 1 (10%) 0 (0%) 1 (10%) 8 (10%) 
AF 6 (60%) 4 (40%) 6 (60%) 25 (31.2%) 
AFL cycle 256 _+ 13 258 _+ 8 248 + 10 245 _+ 26 
length (ms) 
No. of RF 7 _+ 8 8 - 6.5 9 z 8 13.9 + 8 
applications 
Procedure 48 + 22* 81 + 17' 110 + 19" 88 - 48* 
duration (min) 
Fluoroscopy 25 _- 15 28 _+ 10 40 _+ 20 38 _+ 34 
time (rain) 
*p < 0,05 for difference between groups. Data presented are mean value + 
SD or number (%) of patients. RF = radiofrequency; other abbreviations a in 
Table 1. 
observations). Initial reports using radiofrequency energy are 
more promising (8-10). In contrast, with direct current shocks 
that were applied to a diffuse area, atrial flutter interruption 
with radiofrequency energy indicates that a critical area of 
tissue for maintenance of the circuit is modified or ablated. 
Cosio et al. (8) proposed ablation of the area between the 
tricuspid annulus and the inferior vena cava orifice that 
appeared essential for the atrial flutter circuit. In that study the 
end point was immediate interruption ofatrial flutter. Clinical 
success was obtained in eight of nine patients, but five required 
a second session because of recurrence. Another approach 
based on electrophysiologic criteria was reported by Feld et al. 
(9). Sites were characterized by early electrograms and precise 
entrainment pace mapping with short stimulus to P wave 
interval. Atrial flutter did not recur in 11 of 12 patients. Finally, 
Lesh et al. (10), using a combined anatomic and electrophysi- 
ologic approach, obtained a high primary success rate (17 of 18 
patients) but, unfortunately, a high recurrence rate (30%). The 
present study confirms that flutter can be successfully ablated 
with a high success rate. Our approach isprimarily an anatomic 
one and indicates that ablation of atrial flutter can be accom- 
plished by this approach. In some patients only one application 
of radiofrequency energy was needed, but in others extensive 
ablation of the isthmus adjacent to the tricuspid valve was 
necessary. 
Site of successful ablation. At the beginning of our expe- 
rience radiofrequency energy was delivered at appropriate 
sites based primarily on catheter stability. The final successful 
site was located in the low atrial septum at multiple locations 
encompassing the three targeted areas. Most electrograms at 
the final point where energy delivery was successful were 
recorded uring the middle of "plateau phase." However, the 
location and timing of the last pulse may provide limited useful 
information because it was frequently preceded by several 
applications of radiofrequency energy. At times progressive 
changes of the flutter wave configuration occurred before the 
final energy delivery. This suggests hat success was due to the 
summation of radiofrequency-mediated lesions. Therefore, 
the successful pulse probably was the result of the cumulative 
effect of preceding areas of injury. 
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Figure 3. Actuarial analysis of the recurrence rate in patients 
with initial successful ablation. AFL = atrial flutter. 
We assessed the effect of lesions performed at each of the 
three targeted areas (Fig. 4). The highest success (70%) was 
obtained in the inferior vena cava orifice-tricuspid annulus 
isthmus. Lesions in the coronary, sinus ostium-tricuspid annu- 
lus gave a 40% interruption of atrial flutter, whereas lesions 
applied at the inferior vena cava orifice-coronary sinus ostium 
achieved success in only 10%. Furthermore, the summation of 
ablation at the first two areas increased the success rate to 
90%, whereas application of radiofrequency at area 3 after 
failure at area 2 improved success only to 60%. 
The ideal site for ablating reentrant circuits is where the 
reentrant circuit travels through an isthmus bounded by aria- 
Table 5. Comparison of Data in Patients With or Without Recurrence of Atrial Flutter 
All Patients Primary, Success Recurrences Failed Procedures 
(n = 80) (n 58) (n = 14) (n = 8) 
Gender (M/F) 71/9 
Age (yr) 59 + 12 
Cardiac disease 31 
Permanent AFL 51 
Paroxysmal AFL 29 
Ab'pical AFL 8 
AF 25 
AFL cycle length 245 + 26 
No. of RF applications 13.9 + 8 
Electrogram feature during AFL at final successful site 
Atrial elcctrogram amplitude (mVi 0.87 + 0.56 
Ventricular electrogram amplitude (mV) 0.22 + I).37 
AV ratio 7.9 x 7.8 
Fragmented 19 
Double spikes 20 
Single spike 34 
Final successful area 
1 35 
2 25 
3 12 
Time for AFL interruption (s) 22 + 16 
Modification of cycle length before interruption 18 
Electrogram feature after resumption of sinus rhythm 
Atrial electrogram amplitude (mV/ 0.45 _-_ 0.48 
Ventricular electrogram amplitude (mV) 0.10 + 0.27 
AV ratio 5.4 + 6 
Double atrial potential 46 
Procedure duration (rain) 88 + 48 
Fluoroscopy time (min) 38 + 34 
Postablation atrial stimulation 
No arrhythmia 36 
AF 10 
Atypical AFL 34 
52/6 13/1 6/2 
60 +_ 11) 57 + 15 53 +- 17 
24 3 4 
39 9 4 
18 5 4 
6 1 1 
16 7 4 
242 _+ 26 255 _+ 29 254 + 20 
12.6 _+ 7 23.6 _+ 16" 16.7 _+ 7.5 
0.7 _+ 0.5 t.l +_ 0.5t 
(I.20 + 0.4 0.27 _+ 0.3 
8 + 8 6.8 _+ 6.4 
18 1 
15 5 
25 9 
28 7 
21 4 
9 3 
22 _+ 17 25 + 12 
14 4 
(1.4 _+ 0.4 0.42 * 0.7 
0.13 + 0.3 0.07 -+ 0.075 
5.6_+6 5.1_+10 
37 9 
77 + 40 112 _+ 66 
33 + 22 62 _+ 66 
30 6 
7 3 
26 8 
125 _+ 52 
80 -+ 50 
*p = 0.03. )p = (l,04. ;p = 0.0l. Data presented are mean value + SD or number of patients. AV = atrioventricular; other abbreviations a in Tables 1 and 4. 
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Table 6. Results of Radiofrequency Ablation in 80 Patients With Common Atrial Flutter 
Initial results 
AFL interrupted and rendcrcd noninducible: 
72 pts (9091) 
Follo~v-up: 20 + 8 mo 
(mean + SD) 
i 
Failed ablation (no 2nd session): 
8 pts (111%) 
No AFL: 54 pts (76~i) Recurrences: 14 pts (18C~) "New" AF: 4 pts (6%) 
No AFL (2nd/3rd session): lil pts No 2rid session: 4 pts 
Final results 
No AFL: 64 pts (8()5~) AF and/or AFL: 16 pts (20%) 
Abbreviations as in Tables and 3. 
tomic areas of block. In the case of atrial flutter, such a site 
could be either the isthmus between the inferior vena cava 
orifice and the coronary sinus ostium, the isthmus between the 
coronary sinus ostium and the tricuspid valve or the isthmus 
between the inferior vena cava orifice and the tricuspid valve. 
Our results suggest hat the latter target has given the best 
Figure 4. Schematic representation of the circuit in common atrial 
flutter. Arrows show the reentrant circuit, which weaves clockwise 
through the isthmus between the inferior vena cava (IVC) orifice and 
tricuspid valve (TV), up the right atrial septum and back down the 
anterior atrial free wall. Dotted lines show the three ablation areas at 
the isthmus tested in our study (see Methods, Target sites). CS 
coronary, sinus. 
& 
results. One could speculate that the reason for the lower 
success rate when ablating between the inferior vena cava 
orifice and the coronary sinus ostium (area 3) or between the 
coronary sinus ostium and the tricuspid valve (area 2) is that 
the wavefront could then travel through the adjacent isth- 
muses. In fact, the isthmus could then be considered as really 
being between the inferior vena cava orifice and the tricuspid 
valve. The isthmus could be transected either more inferiorly 
(area 1) or more superiorly at the level of the coronary sinus 
ostium (i.e., connecting areas 2 and 3). We think that more 
success is achieved at area 1 than at the site connecting areas 
2 and 3 because of the difficulty in ablating atrial tissue 
surrounding the coronary sinus ostium. Also, in area 3, the 
eustachian valve is interposed and may render it more difficult 
to create a lesion in this area. This tissue may be ablated from 
inside the vein, but this is potentially hazardous. 
Follow-up. Clinical recurrences of atrial flutter occurred in 
17% of patients. When atrial flutter recurred, it had the same 
configuration in all but one patient, suggesting a reversal or 
inadequate amount of tissue damage, or both. A second or 
third session interrupted atrial flutter in all patients without 
recurrence. New energy sources or the use of a longer tipped 
electrode or stabilization of the catheter with a long venous 
sheath might lower the recurrence rate by achieving more 
tissue damage or better contact with the atrial wall, or both. A 
"new" symptomatic atrial fibrillation appeared after ablation 
in four patients. We do not know if this represented an 
arrhythmia related to the ablation or to the natural history of 
arrhythmia in these patients. 
1372 FISCHER ET AL. JACC Vol. 25, No. 6 
RADIOFREQUENCY ABLATION OF ATRIAL FLU'I~ER May 1995:1365-72 
Conclusions. The present study indicates that ablation of 
common atrial flutter using an anatomic approach is effective 
and safe and that various areas between the tricuspid valve, 
inferior vena cava orifice and coronary sinus ostium are 
effective in eliminating atrial flutter. The highest success rate is 
achieved with radiofrequency energy applied in the isthmus 
between the inferior vena cava orifice and tricuspid valve. 
We thank Jo611¢ Bassibey for secretarial ssistance. 
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